You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Illuminare-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma Trial in United States (Illuminare-1, Karl Storz D-Light C photodynamic diagnostic (PDD))

Recruiting
  • Prostate Adenocarcinoma
  • Illuminare-1
  • Karl Storz D-Light C photodynamic diagnostic (PDD)
  • Basking Ridge, New Jersey
  • +5 more
Jun 20, 2022

Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Rheumatoid Arthritis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

COVID-19 Trial in Thái Bình (COVIVAC vaccine)

Completed
  • COVID-19
  • COVIVAC vaccine
  • Thái Bình, Thai Binh, Vietnam
    District Health Center of Vu Thu District
Jul 12, 2023

Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)

Completed
  • Ankylosing Spondylitis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 10, 2023

Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • PIPE-307 Dose A
  • +2 more
  • (no location specified)
Oct 9, 2023

Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of

Not yet recruiting
  • Meningococcal Meningitis
  • batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
  • +3 more
  • Surabaya, Indonesia
    Husada Utama Hospital
Nov 13, 2023

Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • iNKT Cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 24, 2023

Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Atopic Dermatitis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Jianzhong Zhang
Oct 10, 2023

Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

Not yet recruiting
  • Hypertension,Essential
  • Songling Xuemaikang Capsules
  • +2 more
  • Beijing, Beijing, China
  • +4 more
Oct 17, 2023

Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)

Not yet recruiting
  • Diabetes
  • INS062 injection、INS068 injection、HR20014 injection
  • (no location specified)
May 24, 2023

COVID-19 Trial (STI-1558)

Not yet recruiting
  • COVID-19
  • (no location specified)
Sep 15, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 22, 2023

Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )

Recruiting
  • Type1diabetes
  • +2 more
  • Infusion of GIP[1-42], GIP[1-30] or placebo
  • Hellerup, Copenhagen, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 13, 2023

Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

Not yet recruiting
  • Breast Cancer
  • laboratory test (RAI14 and MACC-1 )
  • (no location specified)
Oct 18, 2023

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

HIV Prevention Trial in Worldwide (Placebo rectal insert, Placebo rectal suppository, Placebo rectal douche)

Completed
Has Results
  • HIV Prevention
  • Placebo rectal insert
  • +2 more
  • Birmingham, Alabama
  • +6 more
Jan 4, 2023

Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)

Not yet recruiting
  • Healthy Women of Child Bearing Potential
  • R21/Matrix-M1
  • +2 more
  • (no location specified)
Oct 10, 2023

Tetanus Trial in Bijie (TTVA, TT)

Not yet recruiting
  • Tetanus
  • TTVA
  • TT
  • Bijie, Guizhou, China
    Center for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023

Tetanus Trial in Bijie (TTVA, TT)

Not yet recruiting
  • Tetanus
  • TTVA
  • TT
  • Bijie, Guizhou, China
    Center for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023

Charcot Marie Tooth Disease, Type 1 Trial in Seoul (CLZ-2002)

Recruiting
  • Charcot Marie Tooth Disease, Type 1
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical center
Jul 18, 2023

Generalized Anxiety Disorder Trial (Shugan Jieyu Capsules, Shugan Jieyu Capsules+Placebo, Placebo)

Not yet recruiting
  • Generalized Anxiety Disorder
  • Shugan Jieyu Capsules
  • +2 more
  • (no location specified)
Mar 6, 2023

Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1

Not yet recruiting
  • Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
  • Ivosidenib 500mg
  • Placebo
  • (no location specified)
Nov 7, 2023

Bone Turnover in Childern and Adolescents With Type 1 Diabetes

Not yet recruiting
  • Type 1 Diabetes
  • serum ostecalcin,serum sclerostin and parathroid profile
  • Sohag, Egypt
    Sohag university Hospital
May 29, 2023